The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Treatment of Diarrhea Caused by Cryptosporidium parvum: A Prospective Randomized, Double‐Blind, Placebo‐Controlled Study of Nitazoxanide
Abstract
A prospective randomized, double-blind, placebo-controlled study was conducted in 50 adults and 50 children from the Nile delta of Egypt, to evaluate the efficacy of nitazoxanide in treating diarrhea caused by Cryptosporidium parvum. Nitazoxanide was administered in 500-mg doses twice daily for 3 days in adults and adolescents, in 200-mg doses twice daily for 3 days in children aged 4-11 years, and in 100-mg doses twice daily for 3 days in children aged 1-3 years. At 7 days after initiation of therapy, diarrhea had resolved in 39 (80%) of the 49 patients in the nitazoxanide treatment group, compared with 20 (41%) of 49 in the placebo group (P<.0001). Diarrhea was resolved in most patients receiving nitazoxanide within 3 or 4 days of treatment initiation. Nitazoxanide treatment reduced the duration of both diarrhea (P<.0001) and oocyst shedding (P<.0001).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
(2015) · Elsevier eBooks · doi:10.1016/c2012-1-00075-6 · Cited by 2,577
Practice Guidelines for the Management of Infectious Diarrhea
Guerrant, R. L., Van Gilder, T., Steiner, T. S., Thielman, N. M., Slutsker, L., Tauxe, R. V., Hennessy, T., Griffin, P. M., DuPont, H., Bradley Sack, R., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318514 · Cited by 1,074
Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases
Malani, P. N. (2010) · JAMA · doi:10.1001/jama.2010.1643 · Cited by 805
Guerrant, D. I., Moore, S. R., Lima, A. A., Patrick, P. D., Schorling, J. B., & Guerrant, R. L. (1999) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1999.61.707 · Cited by 469
Rossignol, J., Hidalgo, H., Feregrino-Goyos, M., Higuera, F., Gomez, W. H., Romero, J. L., Padierna, J., Geyne, A., & Ayers, M. S. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90804-5 · Cited by 173
Self-citationEfficacy of Nitazoxanide against Cryptosporidium parvum in Cell Culture and in Animal Models
Theodos, C. M., Griffiths, J. K., D’Onfro, J., Fairfield, A., & Tzipori, S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1959 · Cited by 171
Blagburn, B. L., Drain, K. L., Land, T. M., Kinard, R. G., Moore, P. H., Lindsay, D. S., Patrick, D. A., Boykin, D. W., & Tidwell, R. R. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2877 · Cited by 77
Cited by
Checkley, W., White, A. C., Jaganath, D., Arrowood, M. J., Chalmers, R. M., Chen, X.-M., Fayer, R., Griffiths, J. K., Guerrant, R. L., Hedstrom, L., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70772-8 · Cited by 987
Bhutta, Z. A., Das, J. K., Walker, N., Rizvi, A., Campbell, H., Rudan, I., & Black, R. E. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60648-0 · Cited by 675
Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix669 · Cited by 627
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Rossignol, J.-F. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.07.014 · Cited by 556
Self-citationShane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix959 · Cited by 532
Thielman, N. M., & Guerrant, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp031534 · Cited by 456
Chen, X.-M., Keithly, J. S., Paya, C. V., & LaRusso, N. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra013170 · Cited by 451
Nitazoxanide: A New Thiazolide Antiparasitic Agent
Fox, L. M., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/428839 · Cited by 443
Amadi, B., Mwiya, M., Musuku, J., Watuka, A., Sianongo, S., Ayoub, A., & Kelly, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11401-2 · Cited by 441
Self-citationTreatment of Clostridium difficile-associated disease: old therapies and new strategies
Aslam, S., Hamill, R. J., & Musher, D. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70215-2 · Cited by 366
Metadata
- Authors
- Rossignol, J. A., Ayoub, A., & Ayers, M. S.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07
- Volume
- 184
- Issue
- 1
- Pages
- 103-106
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2086715367
- Cited by
- 362
- References
- 8
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.